Chemo-immunotherapy combination efficacy not impaired by antibiotics

The detrimental effect of antibiotics on the efficacy of immune checkpoint inhibitors (ICIs), does not extend to chemo-immunotherapy combinations in patients with lung cancer, new research shows. An international multicentre study involving 302 patients with stage IV NSCLC found no effect of prior (n= 47 patients) or current antibiotic therapy on the efficacy of first ...

Already a member?

Login to keep reading.

© 2022 the limbic